Abstract
The diagnosis of MSA represents a major challenge in movement disorders clinics. In early disease stages, the parkinsonian variant of MSA (MSA-P) may be indistinguishable from idiopathic PD, whereas in more advanced stages, features overlapping with the clinical presentation of progressive supranuclear palsy (PSP) or dementia with Lewy bodies (DLB) may be also present in MSA. Also, inherited (like late onset atypical Friedreich’s ataxia, spinocerebellar ataxias 2,3 or 6 without an obvious family history) or acquired causes of late-onset cerebellar ataxia need to be ruled out to diagnose cerebellar MSA (MSA-C).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 38:4–24
Albanese A, Colosimo C, Bentivoglio AR, Fenici R, Melillo G, Tonali P (1995) Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry 59:144–151
Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN (2009) Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132:156–171
Boesch SM, Wenning GK, Ransmayr G, Poewe W (2002) Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 72:300–303
Colosimo C (1998) Pisa syndrome in a patient with multiple system atrophy. Mov Disord 13:607–609
Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ (1995) Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease. Arch Neurol 52:294–298
Colosimo C, Vanacore N, Bonifati V, Fabbrini G, Rum A, de Michele G, de Mari M, Bonuccelli U, Nicholl DJ, Meco G (2001) Clinical diagnosis of multiple system atrophy: level of agreement between Quinn’s criteria and the consensus conference guidelines. Acta Neurol Scand 103:261–264
Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F (2002) Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 72:798–800
Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 8:359–362
Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, Masliah E, Low P, Sandroni P, Trojanowski JQ, Ozelius L, Foroud T (2005) The North American Multiple System Atrophy Study Group. J Neural Transm 112:1687–1694
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676
Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y (1995) “Pure” striatonigral degeneration and Parkinson’s disease: a comparative clinical study. Mov Disord 10:288–294
Klein C, Brown R, Wenning G, Quinn N (1997) The “cold hands sign” in multiple system atrophy. Mov Disord 12:514–518
Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK (2008) Red flags for multiple system atrophy. Mov Disord 23:1093–1099
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9
Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y (1998) Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm 105:217–227
Litvan I, Bathia KP, Burn DJ, Goetz CG, Lang AE, Mc Keith I, Quinn N, Sethi KD, Schults C, Wenning GK (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian Disorders. Mov Dis 18(5):467–486
Mitsui J, Matsukawa T, Ishiura H, Fukuda Y, Ichikawa W et al (2013) Mutations of COQ2 in familial and sporadic multiple system atrophy. NEJM, June 12. Epub ahead of print
Muller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I (2001) Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 58:259–264
Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, Quinn N (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59:1486–1491
Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79–100
Pramstaller PP, Wenning GK, Smith SJ, Beck RO, Quinn NP, Fowler CJ (1995) Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry 58:618–621
Quinn N (1989a) Disproportionate antecollis in multiple system atrophy. Lancet 1:844
Quinn N (1989b) Multiple system atrophy – the nature of the beast. J Neurol Neurosurg Psychiatry Suppl:78–89
Quinn N (ed) (1994) Multiple system atrophy. Butterworth-Heinemann, London
Schulz JB, Klockgether T, Petersen D, Jauch M, Muller-Schauenburg W, Spieker S, Voigt K, Dichgans J (1994) Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 57:1047–1056
Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 251:205–208
Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G (2001) Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci 22:247–251
Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1994) Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117(Pt 4):835–845
Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133–147
Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease? J Neurol Neurosurg Psychiatry 68:434–440
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Fanciulli, A., Wenning, G.K. (2014). Clinical Diagnostic Criteria. In: Wenning, G., Fanciulli, A. (eds) Multiple System Atrophy. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0687-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0687-7_7
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0686-0
Online ISBN: 978-3-7091-0687-7
eBook Packages: MedicineMedicine (R0)